Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07072767 · ClinicalTrials.gov registry record · NA
Hybrid Dissemination Study of A Digital-Analog Intervention to Increase Live Donor Kidney Transplantation
A NA study, sponsored by State University of New York at Buffalo.
- Not yet
- Registry status
- NA
- Development phase
- 430
- Enrollment target
NCT07072767: Clinical Trial NA study, sponsored by State University of New York at Buffalo.
NCT07072767 is a NA study that has not yet begun recruiting, run by State University of New York at Buffalo. The registered enrollment target is 430 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (69% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07072767, a NA study, has not yet begun recruiting, sponsored by State University of New York at Buffalo.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 430 participants
- Enrollment target
Study Summary
The study is a 2-arm randomized controlled trial among patients referred for kidney transplant evaluation at a single transplant center to compare the effects of a digital-analog intervention to increase living-donor kidney transplant access (KidneyTIME+) with or without human guide . Following consent and baseline assessment, participants are randomized, stratified by self-reported race, with equal allocation to 2 treatment arms: the KidneyTIME+ intervention with or without human guide.
Primary Outcome
Count of living donor inquires to the transplant center on behalf of the study participants within 6 months from enrollment. Each inquiry (telephone call, email, letter) is counted and added to a discrete field for all patients in the electronic medical record.
Interventions
- BEHAVIORAL Digital education outreach intervention for kidney transplant access and human guide
- BEHAVIORAL Digital education outreach intervention for kidney transplant access only (unguided)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 430 participants |
| Start Date | 2027-01-01 |
| Est. Completion | 2030-07-01 |
| Phase | NA |
What is known before NCT07072767 opens enrollment
NCT07072767 is an interventional study that assigns participants to a tested intervention. The registered 430 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (69% lower).
The record links to 0 conditions, and to 2 interventions - of which Digital education outreach intervention for kidney transplant access and human guide is the first listed.
NCT07072767 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07072767 about?
NCT07072767 is a clinical study titled "Hybrid Dissemination Study of A Digital-Analog Intervention to Increase Live Donor Kidney Transplantation". The study is a 2-arm randomized controlled trial among patients referred for kidney transplant evaluation at a single transplant center to compare the effects of a digital-analog intervention to increase living-donor kidney transplant access (KidneyTIME+) with or without human guide . Following cons...
What is the current status of trial NCT07072767?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 430 participants. The study started on 2027-01-01. Estimated completion is 2030-07-01.
What interventions are being tested in trial NCT07072767?
The interventions under investigation include: Digital education outreach intervention for kidney transplant access and human guide (BEHAVIORAL), Digital education outreach intervention for kidney transplant access only (unguided) (BEHAVIORAL).
Who is sponsoring clinical trial NCT07072767?
This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07072767's enrollment target sits among peer trials
430 235th of 2000 higher than 1,765 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05327023 · 430 participants · Phase 1
Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies
- NCT05457985 · 430 participants · NA
Testing Adaptive Interventions to Improve Posttraumatic Stress Disorder Treatment Outcomes in Federally Qualified Health Centers
- NCT05532982 · 430 participants
Parkinson's Disease in Asian Americans
- NCT05844891 · 430 participants · NA
Telehealth-Enhanced Asthma Care for Home After the Emergency Room
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI